Johnson JL - Search Results

1

Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes.

Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC. Newby AC, et al. Among authors: johnson jl. Thromb Haemost. 2009 Jun;101(6):1006-11. Thromb Haemost. 2009. PMID: 19492140 Free PMC article.

2

Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.

George SJ, Johnson JL, Angelini GD, Jeremy JY. George SJ, et al. Among authors: johnson jl. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2500-6. doi: 10.1161/01.atv.17.11.2500. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409220

3

Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.

George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH. George SJ, et al. Among authors: johnson jl. Hum Gene Ther. 1998 Apr 10;9(6):867-77. doi: 10.1089/hum.1998.9.6-867. Hum Gene Ther. 1998. PMID: 9581909

4

Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques.

Johnson JL, Jackson CL, Angelini GD, George SJ. Johnson JL, et al. Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1707-15. doi: 10.1161/01.atv.18.11.1707. Arterioscler Thromb Vasc Biol. 1998. PMID: 9812908

5

The association of platelet-derived growth factor receptor expression, plaque morphology and histological features with symptoms in carotid atherosclerosis.

Irvine CD, George SJ, Sheffield E, Johnson JL, Davies AH, Lamont PM. Irvine CD, et al. Among authors: johnson jl. Cardiovasc Surg. 2000 Mar;8(2):121-9. doi: 10.1016/s0967-2109(99)00090-3. Cardiovasc Surg. 2000. PMID: 10737348

6

Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse.

Johnson JL, Jackson CL. Johnson JL, et al. Atherosclerosis. 2001 Feb 1;154(2):399-406. doi: 10.1016/s0021-9150(00)00515-3. Atherosclerosis. 2001. PMID: 11166772

7

In situ zymography.

George SJ, Johnson JL. George SJ, et al. Among authors: johnson jl. Methods Mol Biol. 2001;151:411-5. doi: 10.1385/1-59259-046-2:411. Methods Mol Biol. 2001. PMID: 11217316 No abstract available.

8

Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts.

George SJ, Izzat MB, Gadsdon P, Johnson JL, Yim AP, Wan S, Newby AC, Angelini GD, Jeremy JY. George SJ, et al. Among authors: johnson jl. Atherosclerosis. 2001 Apr;155(2):329-36. doi: 10.1016/s0021-9150(00)00588-8. Atherosclerosis. 2001. PMID: 11254903

9

Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein.

Johnson JL, van Eys GJ, Angelini GD, George SJ. Johnson JL, et al. Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1146-51. doi: 10.1161/hq0701.092106. Arterioscler Thromb Vasc Biol. 2001. PMID: 11451743

10

Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.

George SJ, Johnson JL, Smith MA, Jackson CL. George SJ, et al. Among authors: johnson jl. J Vasc Res. 2001 Sep-Oct;38(5):492-501. doi: 10.1159/000051082. J Vasc Res. 2001. PMID: 11561151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,702 results

Search Page

Filters